View More News
Backed by former Google CEO’s VC, a Colorado biotech hatches platform to evolve degraders
June 13, 2024
![](https://cdn.prod.website-files.com/6495789635a4b638273a434b/651204aeadf443b8b56cda3a_feature-image_scaled_2.jpg)
Backed by former Google CEO’s VC, a Colorado biotech hatches platform to evolve degraders
BioLoomics’ goal is to make a degrader from an antibody in one month
June 13, 2024
BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
June 13, 2024
![](https://cdn.prod.website-files.com/6495789635a4b638273a434b/650cbf194a506f9d26c69368_science-in-hd-X_M0YhZGaS4-unsplash.jpg)
BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
Our mission is to make safer, more effective cancer therapeutics.
June 13, 2024
Pre-Seed Extension
June 13, 2024
![](https://cdn.prod.website-files.com/6495789635a4b638273a434b/64be6fd5e813715f49f92816_20190530_national-cancer-institute-jeT_DE3esSI-unsplash.jpg)
Pre-Seed Extension
BioLoomics closed a $575,000 round of pre seed extension funding on May 11, 2021..
June 13, 2024
OEDIT Grant Award
June 13, 2024
![](https://cdn.prod.website-files.com/6495789635a4b638273a434b/651355292c32636b7885a692_Nuclei_Feature-Image-2.png)
OEDIT Grant Award
The Colorado OEDIT provides funding opportunities to small businesses in fourteen industries...
June 13, 2024
BioLoomics Closes $600k Pre-Seed Round to Launch Biosensing Drug Discovery Platform
June 13, 2024
BioLoomics Closes $600k Pre-Seed Round to Launch Biosensing Drug Discovery Platform
We are excited to announce that on May 30, 2019, BioLoomics closed a $600,000 pre-seed round...
June 13, 2024